JPRN-jRCT2080220126未知3 期
PMCJ-9 (BCG Connaught strain) phase III clinical study
ippon Kayaku Co., Ltd.0 个研究点开始时间: 2005年9月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •1. Granting of written informed consent by the patient
- •2. Resection of all tumors by TURBT, tumors are histopathologically confirmed NMIBC
- •( transitional carcinoma).
- •3. Sufficient function of the major organs
- •4. Performance status 0-2 etc.
排除标准
- •1. Muscle-invasive bladder cancer
- •2. Carcinoma in situ (CIS) or history thereof
- •3. History of systemic chemotherapy, intra-arterial chemotherapy or radiation therapy for bladder cancer
- •4. Patient having an immunosuppressive thrapy, etc.
研究者
相似试验
进行中（未招募）
3 期
JCOG1109: A randomized controlled phase III comparing CF versus DCF versus CF-RT as neoadjuvant treatment for locally advanced esophageal cancerclinical stage IB/II/III thoracic esophageal cancerJPRN-jRCTs031180202Kato Ken600
招募中
3 期
JCOG1509: Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer.Gastric cancerJPRN-jRCTs031180350TERASHIMA Masanori470
未知
3 期
Phase 3 Clinical Trial with MD-0901JPRN-jRCT2080222425MOCHIDA PHARMACEUTICAL CO., LTD.250
未知
3 期
Active Phase Study with MD-0901 -Phase 3 Clinical Trial in Patients with Mild to Moderate Active Ulcerative ColitisMild to moderate active ulcerative colitisJPRN-jRCT2080221343MOCHIDA PHARMACEUTICAL CO., LTD.228
未知
3 期
Remission Phase Study with MD-0901 -Phase 3 Clinical Trial in Patients with Ulcerative Colitis in Remission PhaseJPRN-jRCT2080221344MOCHIDA PHARMACEUTICAL CO., LTD.190